Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia

被引：0
|
作者：
Clara Pérez-Rambla
Leonor Puchades-Carrasco
María García-Flores
José Rubio-Briones
José Antonio López-Guerrero
Antonio Pineda-Lucena
机构：
[1] Centro de Investigación Príncipe Felipe,Structural Biochemistry Laboratory
[2] Fundación Instituto Valenciano de Oncología,Laboratory of Molecular Biology
[3] Fundación Instituto Valenciano de Oncología,Department of Urology
[4] Instituto de Investigación Sanitaria La Fe,Drug Discovery Unit
来源：
Metabolomics | 2017年 / 13卷
关键词：
Biomarkers; Metabolomics; Prostate cancer; Benign prostatic hyperplasia; Nuclear magnetic resonance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasia
    Wolff, JM
    Borchers, H
    Brehmer, B
    Brauers, A
    Jakse, G
    UROLOGIA INTERNATIONALIS, 1998, 60 (03) : 152 - 155
  • [42] Evaluation of MicroRNAs as Non-Invasive Diagnostic Markers in Urinary Cells from Patients with Suspected Prostate Cancer
    Borkowetz, Angelika
    Lohse-Fischer, Andrea
    Scholze, Jana
    Lotzkat, Ulrike
    Thomas, Christian
    Wirth, Manfred P.
    Fuessel, Susanne
    Erdmann, Kati
    DIAGNOSTICS, 2020, 10 (08)
  • [43] The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
    De Nunzio, Cosimo
    Kramer, Gero
    Marberger, Michael
    Montironi, Rodolfo
    Nelson, William
    Schroder, Fritz
    Sciarra, Alessandro
    Tubaro, Andrea
    EUROPEAN UROLOGY, 2011, 60 (01) : 106 - 117
  • [44] Multi-omic diagnostics of prostate cancer in the presence of benign prostatic hyperplasia
    Spick, Matt
    Muazzam, Ammara
    Pandha, Hardev
    Michael, Agnieszka
    Gethings, Lee A.
    Hughes, Christopher J.
    Munjoma, Nyasha
    Plumb, Robert S.
    Wilson, Ian D.
    Whetton, Anthony D.
    Townsend, Paul A.
    Geifman, Nophar
    HELIYON, 2023, 9 (12)
  • [45] Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio
    Kaynar, Mehmet
    Yildirim, Mehmet Erol
    Gul, Murat
    Kilic, Ozcan
    Ceylan, Kadir
    Goktas, Serdar
    CANCER BIOMARKERS, 2015, 15 (03) : 317 - 323
  • [46] Cadmium Concentration and Metallothionein Expression in Prostate Cancer and Benign Prostatic Hyperplasia of Humans
    Lee, Jane-Dar
    Wu, Su-Mei
    Lu, Lieng-Yi
    Yang, Ya-Tang
    Jeng, Shaw-Yeu
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (07) : 554 - 559
  • [47] Potential Efficacy of Some African Plants in Benign Prostatic Hyperplasia and Prostate Cancer
    Russo, Giorgio I.
    Cimino, Sebastiano
    Salamone, Costanza
    Madonia, Massimo
    Favilla, Vincenzo
    Castelli, Tommaso
    Morgia, Giuseppe
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (11) : 1564 - 1571
  • [48] Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome
    Wei-Wei Li
    Yan Yang
    Qi-Gang Dai
    Li-Li Lin
    Tong Xie
    Li-Li He
    Jia-Lei Tao
    Jin-Jun Shan
    Shou-Chuan Wang
    Metabolomics, 2018, 14
  • [49] 5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction
    Rittmaster, Roger S.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (02) : 389 - 402
  • [50] Expression and significance of microRNA-205 in prostate cancer and benign prostatic hyperplasia
    Guo, Xiaogang
    Wang, Feng
    Liu, Ying
    Gao, Xingqiang
    Zhang, Min
    Liu, Qianhong
    Lin, Jing
    Li, Jingjing
    Han, Tao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10739 - 10746
12345